Blog

Tian Zhang: Celebrating progress in GU oncology with colleagues

Rana McKay/X

Oct 21, 2024, 08:27

Tian Zhang: Celebrating progress in GU oncology with colleagues

Tian Zhang, Associate Director of Clinical Research at Simmons Comprehensive Cancer Center, shared a post by Rana McKay on X, adding the following:

“You have grown a great group in GU oncology, my friend Dr. Rana McKay! Too short a trip. See y’all again soon Dr. Tyler Stewart and Yu Wei Chen!”

Quoting Rana McKay’s post:

“Awesome to have Tian Zhang speak at our Delivering Discoveries CME lots of exciting progress in GU malignancies!”

Tian Zhang is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center. She specializes in the diagnosis and treatment of genitourinary malignancies. She has gained an international reputation developing clinical trials in kidney, prostate, and bladder cancers. She serves as the study chair for PDIGREE, a phase III trial in metastatic renal cell carcinoma. She serves on numerous committees, including as Co-chair of the National Cancer Institute Genitourinary (GU) Steering Committee Renal Task Force and as Chair of the Chinese American Hematologist and Oncologist Network (CAHON) Academic Committee.

She is a member of several ASCO clinical management guidelines committees as well as the Alliance for Clinical Trials in Oncology, GU Oncology, and Immuno-Oncology Committees. She has received multiple peer-reviewed grants, a Resident Research Mentoring Award from Duke, and, notably, the 2021 Cancer Prevention & Research Institute of Texas (CPRIT) Scholar Rising Stars Award.

Rana McKay is a board-certified medical oncologist and specializes in urogenital cancers, offering treatment for bladder, kidney, prostate, and testicular cancer patients. Leading a multi-disciplinary prostate cancer clinic at UC San Diego, she ensures comprehensive care through collaboration with urologists and radiation oncologists.

As an associate professor, Dr. McKay mentors students and conducts research on clinical trials and novel biomarkers for genitourinary malignancies. Dr. McKay is a member of the American Society of Clinical Oncology and the American Association for Cancer Research.